Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesc Xavier Ruiz

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Design of SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse modelBin Tan, Xiaoming Zhang, Ahmadullah Ansari, et al.
Science Advances|May 30, 2025
Development of enhanced HIV-1 non-nucleoside reverse transcriptase inhibitors with improved resistance and pharmacokinetic profilesZhao Wang, Shawn Rumrill, Dongwei Kang, et al.
Nature|January 21, 2016
Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53Denise Martinez-Zapien, Francesc Xavier Ruiz, Juline Poirson, et al.
Journal of Virology|February 12, 2025
The antiviral BDGR-49 provides protection from lethal, neurotropic Venezuelan equine encephalitis virus intranasal infection in miceEvan P Williams, Yi Xue, Peter Vogel, et al.
Nature|December 14, 2023
Structures, functions and adaptations of the human LINE-1 ORF2 proteinEric T Baldwin, Trevor van Eeuwen, David Hoyos, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Design of SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse modelBin Tan, Xiaoming Zhang, Ahmadullah Ansari, et al.
Science Advances|May 30, 2025
Development of enhanced HIV-1 non-nucleoside reverse transcriptase inhibitors with improved resistance and pharmacokinetic profilesZhao Wang, Shawn Rumrill, Dongwei Kang, et al.
Nature|January 21, 2016
Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53Denise Martinez-Zapien, Francesc Xavier Ruiz, Juline Poirson, et al.
Journal of Virology|February 12, 2025
The antiviral BDGR-49 provides protection from lethal, neurotropic Venezuelan equine encephalitis virus intranasal infection in miceEvan P Williams, Yi Xue, Peter Vogel, et al.
Nature|December 14, 2023
Structures, functions and adaptations of the human LINE-1 ORF2 proteinEric T Baldwin, Trevor van Eeuwen, David Hoyos, et al.
Pageof 2